Renoheed 630 mg

Indication

Prevention and treatment of damage caused by faulty or deficient protein metabolism in chronic kidney disease, used together with a restricted low-protein diet.

Ingredients

• Calcium
• 3
• methyl
• 2
• oxo
• valerate (α
• ketoanalogue to isoleucine) 67 mg
• Calcium
• 4
• methyl
• 2
• oxo
• valerate (α
• ketoanalogue to leucine) 101 mg
• Calcium
• 2
• oxo
• 3
• phenylpropionate (α
• ketoanalogue to phenylalanine) 68 mg
• Calcium
• 3
• methyl
• 2
• oxo
• butyrate (α
• ketoanalogue to valine) 86 mg
• Calcium
• DL
• 2
• hydroxy
• 4
• (methylthio)
• butyrate (α
• hydroxyanalogue to methionine) 59 mg
• Lysine acetate 105 mg (= L
• lysine 75 mg)
• L
• Threonine 53 mg
• L
• Tryptophan 23 mg
• Histidine hydrochloride monohydrate 38 mg (eq. to histidine 30 mg)
• L
• Tyrosine 30 mg

Direction

Take orally with meals, swallowed whole, as directed by the doctor or dietician. The usual adult dose is 4 to 8 tablets three times a day (for about 70 kg body weight) together with a low-protein diet.

Side effects

• Hypercalcaemia (raised blood calcium) may occur.
• Consult a doctor or pharmacist before use and stop if irritation or allergy occurs.

Precautions

• Do not use in hypercalcaemia or disturbed amino acid metabolism.
• Contains phenylalanine
• take care in hereditary phenylketonuria.
• Blood calcium levels should be monitored regularly.
• Consult a doctor or pharmacist before use and stop if irritation or allergy occurs.